These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9226457)

  • 1. Using genetically modified mice to study apolipoprotein B.
    Young SG
    J Atheroscler Thromb; 1996; 3(2):62-74. PubMed ID: 9226457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transgenic mice expressing high plasma concentrations of human apolipoprotein B100 and lipoprotein(a).
    Linton MF; Farese RV; Chiesa G; Grass DS; Chin P; Hammer RE; Hobbs HH; Young SG
    J Clin Invest; 1993 Dec; 92(6):3029-37. PubMed ID: 8254057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic analysis of mice expressing exclusively apolipoprotein B48 or apolipoprotein B100.
    Farese RV; Véniant MM; Cham CM; Flynn LM; Pierotti V; Loring JF; Traber M; Ruland S; Stokowski RS; Huszar D; Young SG
    Proc Natl Acad Sci U S A; 1996 Jun; 93(13):6393-8. PubMed ID: 8692825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Susceptibility to atherosclerosis in mice expressing exclusively apolipoprotein B48 or apolipoprotein B100.
    Véniant MM; Pierotti V; Newland D; Cham CM; Sanan DA; Walzem RL; Young SG
    J Clin Invest; 1997 Jul; 100(1):180-8. PubMed ID: 9202070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutagenesis of the human apolipoprotein B gene in a yeast artificial chromosome reveals the site of attachment for apolipoprotein(a).
    McCormick SP; Ng JK; Taylor S; Flynn LM; Hammer RE; Young SG
    Proc Natl Acad Sci U S A; 1995 Oct; 92(22):10147-51. PubMed ID: 7479743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new approach for studying gene regulation by distant DNA elements in transgenic mice.
    Nielsen LB; McCormick SP; Young SG
    Scand J Clin Lab Invest Suppl; 1999; 229():33-9. PubMed ID: 10097288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoprotein clearance mechanisms in LDL receptor-deficient "Apo-B48-only" and "Apo-B100-only" mice.
    Véniant MM; Zlot CH; Walzem RL; Pierotti V; Driscoll R; Dichek D; Herz J; Young SG
    J Clin Invest; 1998 Oct; 102(8):1559-68. PubMed ID: 9788969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transgenic mice expressing high levels of human apolipoprotein B develop severe atherosclerotic lesions in response to a high-fat diet.
    Purcell-Huynh DA; Farese RV; Johnson DF; Flynn LM; Pierotti V; Newland DL; Linton MF; Sanan DA; Young SG
    J Clin Invest; 1995 May; 95(5):2246-57. PubMed ID: 7738190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural relationship of human apolipoprotein B48 to apolipoprotein B100.
    Innerarity TL; Young SG; Poksay KS; Mahley RW; Smith RS; Milne RW; Marcel YL; Weisgraber KH
    J Clin Invest; 1987 Dec; 80(6):1794-8. PubMed ID: 3680528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein B mRNA editing: a key controlling element targeting fats to proper tissue.
    Davidson NO
    Ann Med; 1993 Dec; 25(6):539-43. PubMed ID: 8292303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transgenic mice that overexpress mouse apolipoprotein B. Evidence that the DNA sequences controlling intestinal expression of the apolipoprotein B gene are distant from the structural gene.
    McCormick SP; Ng JK; Véniant M; Borén J; Pierotti V; Flynn LM; Grass DS; ConnollyA ; Young SG
    J Biol Chem; 1996 May; 271(20):11963-70. PubMed ID: 8662599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of the low density lipoprotein receptor-binding site in apolipoprotein B100 and the modulation of its binding activity by the carboxyl terminus in familial defective apo-B100.
    Boren J; Lee I; Zhu W; Arnold K; Taylor S; Innerarity TL
    J Clin Invest; 1998 Mar; 101(5):1084-93. PubMed ID: 9486979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The DNA sequences required for apolipoprotein B expression in the heart are distinct from those required for expression in the intestine.
    Nielsen LB; Sullivan M; Vanni-Reyes T; Goldberg IJ; Young SG
    J Mol Cell Cardiol; 1999 Apr; 31(4):695-703. PubMed ID: 10329198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein B RNA editing enzyme-deficient mice are viable despite alterations in lipoprotein metabolism.
    Morrison JR; Pászty C; Stevens ME; Hughes SD; Forte T; Scott J; Rubin EM
    Proc Natl Acad Sci U S A; 1996 Jul; 93(14):7154-9. PubMed ID: 8692961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apo B100-containing lipoproteins are secreted by the heart.
    Borén J; Véniant MM; Young SG
    J Clin Invest; 1998 Mar; 101(6):1197-202. PubMed ID: 9502759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transgenic mice expressing human ApoB95 and ApoB97. Evidence that sequences within the carboxyl-terminal portion of human apoB100 are important for the assembly of lipoprotein.
    McCormick SP; Ng JK; Cham CM; Taylor S; Marcovina SM; Segrest JP; Hammer RE; Young SG
    J Biol Chem; 1997 Sep; 272(38):23616-22. PubMed ID: 9295301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma carboxyl ester lipase activity modulates apolipoprotein B-containing lipoprotein metabolism in a transgenic mouse model.
    Li L; Weng W; Harrison EH; Fisher EA
    Metabolism; 2008 Oct; 57(10):1361-8. PubMed ID: 18803939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNA editing: a novel mechanism for regulating lipid transport from the intestine.
    Scott J; Wallis SC; Davies MS; Wynne JK; Powell LM; Driscoll DM
    Gut; 1989 Nov; 30 Spec No(Spec No):35-43. PubMed ID: 2606364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of human apolipoprotein B90 in transgenic mice. Demonstration that apolipoprotein B90 lacks the structural requirements to form lipoprotein.
    McCormick SP; Linton MF; Hobbs HH; Taylor S; Curtiss LK; Young SG
    J Biol Chem; 1994 Sep; 269(39):24284-9. PubMed ID: 7929084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced susceptibility to cholesterol gallstone formation in mice that do not produce apolipoprotein B48 in the intestine.
    Wang HH; Wang DQ
    Hepatology; 2005 Oct; 42(4):894-904. PubMed ID: 16175613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.